Electric Fibroscan Mini Plus for Accurate Liver Testing

Product Description

Products Description

A FibroScan is a specialized medical device used to assess liver health, specifically to measure liver stiffness and fat content.
It is a non-invasive tool that helps in diagnosing and monitoring liver conditions such as fibrosis (scarring) and steatosis
(fatty liver). Here's an overview of how it works and its applications:

----------------------------------------------------------------------------------------------------------------------------------

How FibroScan Works
1. Technology:
* FibroScan uses transient elastography, a technique that sends a painless vibration wave through the liver to measure its stiffness.
* It also uses Controlled Attenuation Parameter (CAP) to assess the amount of fat in the liver.

2. Procedure:
* A probe is placed on the skin over the liver area.
* The device sends a low-frequency vibration wave through the liver and measures how quickly the wave propagates. Stiffer liver tissue (indicating fibrosis) transmits the wave faster.
* The results are displayed as a numerical value in kilopascals (kPa) for stiffness and decibels per meter (dB/m) for fat
content.

3. Advantages:
* Non-invasive and painless.
* Quick procedure (usually takes 5-10 minutes).
* No need for sedation or recovery time.
* Provides immediate results.
----------------------------------------------------------------------------------------------------------------------------------

Applications of FibroScan
1. Liver Fibrosis Assessment:
* Detects and stages liver fibrosis (from F0 to F4, where F4 indicates cirrhosis).
* Useful for monitoring chronic liver diseases like hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD).

2. Fatty Liver Evaluation:
* Measures the degree of steatosis (fat accumulation in the liver).
* Helps in diagnosing and managing non-alcoholic steatohepatitis (NASH).

3. Monitoring Disease Progression:
* Tracks changes in liver stiffness and fat content over time.
* Assesses the effectiveness of treatments for liver diseases.

4. Screening Tool:
* Used in at-risk populations (e.g., obese individuals, diabetics, or those with alcohol use disorder) to detect early signs
of liver damage.

----------------------------------------------------------------------------------------------------------------------------------
Key Features of the FibroScan Machine
* Probes: Different probes are available for adults and children, as well as for patients with varying body types.
* Portability: Some models are compact and portable, making them suitable for use in clinics or remote areas.
* User-Friendly: Designed for ease of use by healthcare professionals.

----------------------------------------------------------------------------------------------------------------------------------
Limitations
* Accuracy: May be less accurate in obese patients or those with ascites (fluid in the abdomen).
* Interpretation: Results should be interpreted in the context of other clinical findings and tests.
* Cost: The machine can be expensive, which may limit its availability in some settings.

----------------------------------------------------------------------------------------------------------------------------------
Comparison with Other Diagnostic Tools
* Liver Biopsy: FibroScan is less invasive and avoids the risks associated with biopsies, but it may not replace biopsies in all cases.
* Ultrasound: While traditional ultrasound can detect liver abnormalities, FibroScan provides more specific quantitative data on stiffness and fat content.
* MRI: MRI elastography is another non-invasive option but is more expensive and less accessible than FibroScan.

----------------------------------------------------------------------------------------------------------------------------------
Conclusion

The FibroScan is a valuable tool in hepatology for non-invasive liver assessment. It is widely used for diagnosing and managing
liver diseases, reducing the need for invasive procedures like liver biopsies. However, it should be used as part of a
comprehensive diagnostic approach, considering patient history, physical examination, and other tests.

Details Images

Product Paramenters

Technical Parameters
Product Name	Liver Elastography Machine
Product Model	UMFBSB002
Technology	VCTE™ (Vibration-Controlled Transient Elastography) and CAP™ (Controlled Attenuation Parameter)
Measurement Range (Liver Stiffness)	Expressed in kPa (kilopascals)
Measurement Range (Liver Steatosis)	Expressed in dB/m (decibels per meter)
Sample Volume	Exceeds 3 cm³ (100 times larger than a biopsy sample)
Probe Compatibility	M+ and XL+ probes for CAP™ measurements
Battery Life	Operates for over 2 hours on a built-in battery
Clinical Validation	Supported by 3,500+ peer-reviewed publications
Accuracy (AUROC)	Ranges from 0.70 to 0.99 for fibrosis and steatosis assessment across various liver diseases
Portability	Lightweight and easy to carry, designed for on-the-go use
Applications	Suitable for chronic liver diseases, including HBV, HCV, NAFLD, ALD, and post-liver transplant follow-up

 

Innovative Non-Invasive Quantitative Diagnostic Technology for Liver Stiffness and Steatosis

The Liver Elastography Machine is a portable, lightweight, and easy-to-carry device designed for non-invasive, accurate, and reliable assessment of liver stiffness and steatosis. It enables patient screening and follow-up anytime, anywhere, making it a versatile tool for healthcare professionals.

----------------------------------------------------------------------------------------------------------------------------------

Key Technologies
VCTE™ (Vibration-Controlled Transient Elastography)
* Shear Wave Generation: The probe generates shear waves at a fixed frequency (50Hz), and their propagation speed through the liver is measured via ultrasound to calculate liver stiffness.
* Large Sample Volume: Measures a liver sample volume exceeding 3 cm³ (at least 100 times larger than a biopsy sample).
* Results: Expressed as E (kPa), providing a quantitative measure of liver stiffness.

CAP™ (Controlled Attenuation Parameter)
* Steatosis Quantification: Quantifies liver steatosis by measuring ultrasound attenuation in the liver.
* Validation: CAP values are measured only when the stiffness measurement is valid.
* Probe Compatibility: CAP can be detected using both M+ and XL+ probes.
* Results: Expressed in dB/m, offering a precise measure of liver fat content.

----------------------------------------------------------------------------------------------------------------------------------

Product Highlights
* Global Leader in Transient Elastography: Liver Elastography Machine features patented technology clinically validated for non-invasive quantitative assessment of liver stiffness and steatosis.
* Comprehensive Liver Evaluation: Assesses liver fibrosis and steatosis caused by various etiologies, enhancing diagnostic capabilities for liver diseases.
* Evidence-Based: Supported by over 3,500 peer-reviewed publications, ensuring broad clinical applicability.
* Versatile Applications: Suitable for routine examinations in all chronic liver diseases, from general screening to post-liver
transplant follow-up and prognosis assessment.
* Standalone or Adjunct Tool: Can be used independently or alongside liver biopsy to provide precise decision-making support for patient management.

----------------------------------------------------------------------------------------------------------------------------------

Clinical Applications

01. Chronic Hepatitis B (HBV)
* Liver Stiffness: Closely correlated with the degree of liver fibrosis in HBV patients.
* CAP Efficacy: High diagnostic accuracy for steatosis, with AUROCs of 0.88 (S>1), 0.92 (S≥2), and 0.94 (S>3).

02. Chronic Hepatitis C (HCV)
* Fibrosis Diagnosis: High accuracy for significant fibrosis, severe fibrosis, and cirrhosis, with AUROCs of 0.79, 0.91, and 0.97, respectively.
* CAP Performance: AUROCs for detecting liver steatosis are 0.8 (S1), 0.86 (S≥2), and 0.88 (S≥3).

03. HCV-HIV Coinfection
* Fibrosis Prediction: Accurately predicts liver fibrosis stages, with AUROCs of 0.80, 0.93, and 0.99 for significant fibrosis,
severe fibrosis, and cirrhosis, respectively.

04. Non-Alcoholic Fatty Liver Disease (NAFLD)
* Steatosis and Fibrosis Assessment: CAP and LSM assess liver steatosis and fibrosis, with AUROCs ranging from 0.70 to 0.89.

05. Alcoholic Liver Disease (ALD)
* Fibrosis Assessment: AUROCs for liver fibrosis are 0.84 (F≤1), 0.91 (F≥2), 0.90 (F≥3), and 0.92 (F=4).


06. Liver Cancer
* Esophageal Varices Prediction: Liver stiffness measurement (LSM) positively correlates with the degree of esophageal varices (EV), with an AUROC of 0.76 for EV prediction.
* Sensitivity: At an LSM of 17.6 kPa, the sensitivity for predicting EV is 90%.

07. Biliary Diseases
* Fibrosis Correlation: Strong correlation with fibrosis in biliary diseases (e.g., primary biliary cholangitis, primary
sclerosing cholangitis).
* Diagnostic Efficacy: AUROCs for diagnosing significant fibrosis, severe fibrosis, or cirrhosis are 0.92, 0.86, 0.95, and 0.96.

08. Autoimmune Liver Disease
* Fibrosis Correlation: Closely correlates with fibrosis in autoimmune hepatitis patients, with an AUROC of 0.95 for cirrhosis diagnosis.

09. Drug-Induced Liver Injury (DILI)
* Fibrosis Diagnosis: Optimal diagnostic performance for fibrosis stages S1, S2, S3, and S4, with AUROCs of 0.81, 0.775, 0.798, and 0.896, respectively.

10. Large-Scale Population Screening
* Cost-Effective: Ideal for screening fatty liver and fibrosis in routine health check-ups.

11. Post-Liver Transplant Follow-Up
* Fibrosis Differentiation: LSM can differentiate between rapid and slow fibrosing patients post-transplant.
* Risk Prediction: A simple score combining bilirubin, LSM, or donor age and 6-month LSM accurately predicts significant fibrosis or portal hypertension risk in HCV patients post-transplant.

12. Metabolic-Associated Fatty Liver Disease (MAFLD)
* Steatosis Detection: CAP is more sensitive than ultrasound in detecting steatosis.

----------------------------------------------------------------------------------------------------------------------------------

Advantages of Liver Elastography Machine
* User-Friendly Design: Easy to operate with standardized procedures.
* Immediate Results: High reproducibility and quick turnaround time.
* Dual Metrics: Combines VCTE™ and CAP™ for comprehensive liver assessment.
* Portable: Built-in battery operates for over 2 hours, ideal for on-the-go use.
* Clinically Validated: Supported by extensive research and peer-reviewed publications.


----------------------------------------------------------------------------------------------------------------------------------

Clinical Value
* Accurate and Reliable: Reduces the need for invasive procedures like liver biopsy.
* Wide Applicability: Suitable for screening, diagnosis, treatment monitoring, and prognosis assessment.
* Efficient and Convenient: Portable design ideal for large-scale screening and primary healthcare settings.
* Evidence-Based: Extensive clinical research validates its effectiveness, offering scientific support for clinical decision-making.


----------------------------------------------------------------------------------------------------------------------------------

Why Choose Liver Elastography Machine?
Liver Elastography Machine is a trusted, non-invasive solution for liver health assessment, offering unparalleled accuracy, ease of use, and clinical versatility. Whether for routine screening or specialized diagnostics, Liver Elastography Machine empowers healthcare providers to deliver better patient outcomes.

Order now to enhance your diagnostic capabilities with Liver Elastography Machine!

Product packaging

Certifications

Company Profile

Why Choose Us

Quality Control

1. Design and Manufacturing: The design and manufacturing process of our medical equipment adheres to strict quality standards. We use high-quality materials and components to ensure the durability and reliability of each device.

2. Quality Management System: Our company implements internationally recognized quality management systems, ensuring that every step, from raw material procurement to finished product delivery, meets stringent quality requirements.

3. Employee Training: We provide professional training for our employees on the operation and maintenance of medical equipment, ensuring they are fully knowledgeable about proper usage and maintenance procedures.

Testing Process

1. Factory Inspection: Before leaving the factory, each piece of medical equipment undergoes a series of tests, including but not limited to output performance, image quality, and device stability, to ensure it meets the design standards.

2. Regular Calibration: Medical equipment requires regular calibration during its lifecycle to ensure accurate output and stable performance, maintaining optimal image quality and functionality.

3. Performance Testing: We regularly conduct performance tests, including dose rate testing, image resolution testing, contrast tests, and more, to evaluate whether the equipment's performance aligns with the set standards.

4. Safety Inspections: We conduct comprehensive safety checks on the medical equipment, including radiation protection and electrical safety, ensuring that the device poses no harm to operators or patients during use.

5. Software Updates: As technology evolves, we regularly update the software of our medical equipment to enhance performance, features, and functionality.

FAQ

Q1: What is your minimum order quantity (MOQ)?
A1: Our minimum order quantity is 1 set.

Q2: What payment methods do you accept?
A2: We accept payments via T/T, Western Union, Visa credit card, and other methods.

Q3: What is the lead time?
A3: After receiving payment, the lead time for X-ray machines and accessories is within 15 working days.

Q4: Are your products customizable?
A4: Yes, we offer OEM and ODM services.

Q5: What is your warranty?
A5: Our warranty is 12 months, free of charge.

Q6: Do you accept OEM/ODM orders?
A6: Yes, we can customize products with your brand.